Concepedia

Jérôme Guillemont

JG

Statistics

Publications

31

Citations

5K

H-Index

23

Active since

1991

Affiliations

Johnson & Johnson (United States)(Current)

Johnson & Johnson (France)

Centre National de la Recherche Scientifique

Janssen (Belgium)

Janssen (France)

Jérôme Guillemont is an author at Johnson & Johnson (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1991–2024

31

Publications

31

A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>

Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.2K citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Diarylquinolines target subunit c of mycobacterial ATP synthase

Anil Koul, Najoua Dendouga, Karen Vergauwen et al. · Nature Chemical Biology · 2007 · 548 citations · Full text

Life Sciences, Biochemistry, Microbiology +10

Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis

Anil Koul, Luc Vranckx, Najoua Dendouga et al. · Journal of Biological Chemistry · 2008 · 367 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Structure of the mycobacterial ATP synthase F <sub>o</sub> rotor ring in complex with the anti-TB drug bedaquiline

Julian D. Langer, Luise Eckhardt-Strelau, Jérôme Guillemont et al. · Science Advances · 2015 · 293 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +16

Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue

Anna C. Haagsma, Rooda Abdillahi-Ibrahim, Marijke J. Wagner et al. · Antimicrobial Agents and Chemotherapy · 2008 · 221 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

1–5 of 31